Source:http://linkedlifedata.com/resource/pubmed/id/10406837
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-8-2
|
pubmed:abstractText |
Torasemide is a loop diuretic that is effective at low once-daily doses in the treatment of arterial hypertension. Because its antihypertensive mechanism of action may not be based entirely on the elimination of salt and water from the body, a vasodilator effect of this drug can be considered. In the present study, the ability of different concentrations of torasemide to modify angiotensin II (Ang II)-induced vascular responses was examined, with the use of an organ bath system, in endothelium-denuded aortic rings from spontaneously hypertensive rats. Ang II-induced increases of intracellular free calcium concentration ([Ca(2+)](i)) were also examined by image analysis in cultured vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rats. A dose-response curve to Ang II was plotted for cumulative concentrations (from 10(-9) to 10(-6) mol/L) in endothelium-denuded aortic rings (pD(2)=7.5+/-0.3). Isometric contraction induced by a submaximal concentration of Ang II (10(-7) mol/L) was reduced in a dose-dependent way by torasemide (IC(50)=0.5+/-0.04 micromol/L). Incubation of VSMCs with different concentrations of Ang II (from 10(-10) to 10(-6) mol/L) resulted in a dose-dependent rise of [Ca(2+)](i) (pD(2)=7.5+/-0.3). The stimulatory effect of [Ca(2+)](i) induced by a submaximal concentration of Ang II (10(-7) mol/L) was blocked by torasemide (IC(50)=0.5+/-0.3 nmol/L). Our findings suggest that torasemide blocks the vasoconstrictor action of Ang II in vitro. This action can be related to the ability of torasemide to block the increase of [Ca(2+)](i) induced by Ang II in VSMCs. It is proposed that these actions might be involved in the antihypertensive effect of torasemide observed in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Furosemide,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/irbesartan,
http://linkedlifedata.com/resource/pubmed/chemical/torsemide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0194-911X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
138-43
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10406837-Angiotensin II,
pubmed-meshheading:10406837-Animals,
pubmed-meshheading:10406837-Antihypertensive Agents,
pubmed-meshheading:10406837-Aorta,
pubmed-meshheading:10406837-Biphenyl Compounds,
pubmed-meshheading:10406837-Calcium,
pubmed-meshheading:10406837-Cells, Cultured,
pubmed-meshheading:10406837-Endothelium, Vascular,
pubmed-meshheading:10406837-Furosemide,
pubmed-meshheading:10406837-Hypertension,
pubmed-meshheading:10406837-Intracellular Membranes,
pubmed-meshheading:10406837-Male,
pubmed-meshheading:10406837-Muscle, Smooth, Vascular,
pubmed-meshheading:10406837-Rats,
pubmed-meshheading:10406837-Rats, Inbred SHR,
pubmed-meshheading:10406837-Sulfonamides,
pubmed-meshheading:10406837-Tetrazoles,
pubmed-meshheading:10406837-Vasoconstriction
|
pubmed:year |
1999
|
pubmed:articleTitle |
Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats.
|
pubmed:affiliation |
Vascular Pathophysiology Unit, Department of Cardiology, School of Medicine, University of Navarra, Pamplona, Spain.
|
pubmed:publicationType |
Journal Article
|